Lenovo Earns Multiple Leader Positions and Rising Star Designation in 2026 Future of Work Evaluations by Information Services Group

As AI reshapes the digital workplace, enterprises are under growing pressure to improve employee productivity while reducing the complexity of IT operations and controlling costs. Independent research by Information Services Group (ISG) shows that organizations are addressing these demands with LenovoDigital Workplace Solutions(DWS), applying one integrated approach to transform how IT teams manage everything from devices and lifecycle services to enabling more automated, AI-powered support experiences. With DWS, organizations around the world are moving beyond fragmented, reactive support models, helping prevent or...
Anglais

Airship Achieves ISO 42001 Certification, Clearing the Path for Responsible Enterprise AI

Airship, the mobile-first customer experience company, today announced it has achieved ISO 42001 certification, the global benchmark for Artificial Intelligence Management Systems (AIMS). Certified following an independent audit by A-LIGN, Airship is among the first in the CX industry to earn this standard across its platform. This certification provides enterprise brands with an independently verified foundation to scale AI-driven customer...
Anglais

Incode launches TrustGraph, the first trust network built for the agentic era

Incode Technologies, the global leader in AI-powered identity verification and fraud prevention, today launched TrustGraph, the privacy-preserving trust network that enables institutions to detect repeat fraud and agentic fraud, as well as to recognize legitimate customers with signals from across the network, without pooling, exchanging or exposing customer data. In Incode's early access program, institutions using TrustGraph...
Anglais
09/02/2026 12:00
NTT Transatel enhances the eSIM Bootstrap Connectivity Experience on the latest Samsung Galaxy Z Series

NTT Transatel, a global cellular connectivity provider and subsidiary of NTT Group, today announced its collaboration with Samsung Electronics Co., Ltd. to enhance the eSIM bootstrap connectivity experience on the Galaxy Z series in the United States. Leveraging NTT Transatel's multi-network eSIM expertise and connectivity platform, the companies are helping simplify smartphone activation by enabling secure connectivity during device setup. The collaboration is designed to help reduce connect...

09/02/2026 12:00
Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, SSE: 688796; HKEX: 02315) today announced that it has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical Co., Ltd. (“Qilu Pharmaceutical”) for a fully human VHH antibody molecule. Under the agreement, Biocytogen will grant Qilu Pharmaceutical non-exclusive rights to a fully human VHH antibody molecule to support its research and development of innovative therapeutics in the neuroscience field. The licensed VH...

09/02/2026 12:00
Owkin to License K Pro AI Scientist and Multimodal Oncology and Immunology Data to Boehringer Ingelheim

Owkin, the agentic AI company striving to transform drug discovery and development for biopharma, today announced a license agreement with Boehringer Ingelheim for K Pro, Owkin’s AI Scientist, together with multimodal patient data, aiming to speed up the discovery process across multiple indications in oncology and immunology. This agreement builds upon an initial pilot undertaken by Owkin with Boehringer in 2025. In that pilot Owkin delivered deep spatial insights into the tumor microenviron...

09/02/2026 12:00
Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, SSE: 688796; HKEX: 02315) today announced that it has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical Co., Ltd. (“Qilu Pharmaceutical”) for a fully human VHH antibody molecule. Under the agreement, Biocytogen will grant Qilu Pharmaceutical non-exclusive rights to a fully human VHH antibody molecule to support its research and development of innovative therapeutics in the neuroscience field. This press relea...

Subscribe to